Rapid Response: Canada 2020 (Alzheimer’s & Related Diseases / Parkinson’s & Related Diseases)

SUBMIT A LETTER OF INTENT

Sign in to our online system or register for a new account to submit a letter of intent.

Closed

*The deadline for submitting applications to the Rapid Response: Canada 2020 (Parkinson’s & Related Diseases / Alzheimer’s & Related Diseases) program has now passed*

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.

The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. Preliminary data is not required.

Please note: Some deadlines for the Rapid Response: Canada 2020 program have been extended. Please see below.


Continuing for 2020:

  • The budget of the Rapid Response: Canada 2020 program has been increased to a maximum of $300,000 over up to 18 months.
  • Expanding the type of complementary approaches eligible for funding to other lifestyle interventions including but not limited to: speech therapy, cognitive therapy, music therapy, social interaction, if these applications meet our other scope criteria and have specific supportive evidence/justification (from published literature or unpublished data) to warrant further investigation.
  • Encouraging applications that bring in other fields such as: AI, big data, machine learning, data science, and computer science.

Program Overview

Goal: To provide seed funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

Funding: A maximum of $300,000 over up to 18 months per project.

Applicant Eligibility: Eligible Principal Applicants must be working in Canada at least 30% of the time at or above the level of Postdoctoral researcher, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-Applicants/Collaborators must be at the post-doctoral level or above and can be working outside Canada.

If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) who is at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.

Applicants may appear in any role on any number of projects.

Project Eligibility: Projects must meet two conditions to be eligible:

  • Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging
  • Be the development of a therapeutic and/or tool, and/or select complementary approaches (Please refer to the Program Details for more information)

*Preliminary data is not required for this program

Please refer to What We Fund for Institute definitions of neurodegenerative diseases of aging, translational research, therapeutic/tool, and complementary approaches.

The Rapid Response program will have multiple calls per year, alternating between two different disease groups (outlined below). Applicants should apply to the group best suited to their project.

Alzheimer’s & Related Diseases: Parkinson’s & Related Diseases:
o Alzheimer’s disease o Parkinson’s disease
o Frontotemporal dementia o Dementia with Lewy bodies
o Mild cognitive impairment o Multiple system atrophy
o Vascular contributions to the above o Progressive supranuclear palsy
o Prodromes to the above o Vascular contributions to the above
o Prodromes to the above

The Institute welcomes additional inquiries about this program, including whether a potential idea is in scope. For questions related to the Alzheimer’s & Related Diseases program, please contact Michael Jones. For questions related to the Parkinson’s & Related Diseases program, please contact Matthew Sacheli.


Application Process

There are two stages of the application process:

  1. Letter of Intent (LOI)
  2. Full Proposal

An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be sent to those invited.

Program Details

Alzheimer’s & Related Diseases (AD, FTD, MCI, and vascular contributions and prodromes to the listed diseases)

Request for Applications (RFA)

LOI Sample

Parkinson’s & Related Diseases (PD, PSP, DLB, MSA, prodromes, and vascular contributions to the listed diseases)

Request for Applications (RFA)

LOI Sample


Important Dates

Please note: Some deadlines for the Rapid Response: Canada 2020 program have been extended.

Alzheimer’s & Related Diseases:
Online applications open: February 5, 2020
LOI deadline: March 27, 2020 April 24, 2020 at 2:00pm ET
Proposal deadline: August 5, 2020 August 20, 2020 at 2:00pm ET
Anticipated award notification: October 2020
Parkinson’s & Related Diseases:
Online applications open: February 5, 2020
LOI deadline: April 30, 2020 June 4, 2020 at 2:00pm ET
Proposal deadline: September 22, 2020 October 13, 2020 at 2:00pm ET
Anticipated award notification: December 2020

 


Program Information Webinar

The Institute will hold a Program Information Webinar for each disease focus, to provide further details on the program and answer any questions. However, if you have questions specific to your project (e.g., project scope), we encourage you to contact us.

Alzheimer’s & Related Diseases: February 24, 2020 at 1:00pm ET
The webinar has passed.

Parkinson’s & Related Diseases: March 20, 2020 at 1:00pm ET
The webinar has passed.


 

Back to Programs